QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
QQQ   283.85 (+1.18%)
AAPL   142.65 (+1.21%)
MSFT   247.40 (+1.24%)
META   115.33 (+1.23%)
GOOGL   93.71 (-1.30%)
AMZN   90.35 (+2.14%)
TSLA   173.44 (-0.34%)
NVDA   171.69 (+6.51%)
NIO   13.41 (+6.60%)
BABA   94.17 (+6.61%)
AMD   70.47 (+0.47%)
T   19.12 (-0.93%)
MU   55.20 (+2.56%)
CGC   3.09 (-4.63%)
F   13.12 (+0.15%)
GE   83.63 (-1.61%)
DIS   92.55 (+0.43%)
AMC   6.07 (+0.33%)
PYPL   74.22 (-0.27%)
PFE   51.78 (+3.07%)
NFLX   310.26 (+0.60%)
OTCMKTS:OPHLF

Ono Pharmaceutical - OPHLF Stock Forecast, Price & News

$24.14
0.00 (0.00%)
(As of 12/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$24.14
$24.14
50-Day Range
$22.80
$25.17
52-Week Range
$22.69
$27.76
Volume
N/A
Average Volume
483 shs
Market Capitalization
$12.41 billion
P/E Ratio
16.53
Dividend Yield
N/A
Price Target
N/A
OPHLF stock logo

About Ono Pharmaceutical (OTCMKTS:OPHLF) Stock

Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; DEMSER capsules for improvement of the symptoms in patients with pheochromocytoma; and MEKTOVI, VELEXBRU, and ADLUMIZ tablets, as well as BRAFTOVI capsules for malignant tumors. The company also provides GLACTIV and FORXIGA tablets for type 2 diabetes; FORXIGA tablets for the treatment of diabetes; ONOACT injections for tachyarrhythmia; OPALMON tablets to treat peripheral circulatory disorder; CORALAN for treatment of chronic heart failure; ORENCIA injections for rheumatoid arthritis; RIVASTACH patches for Alzheimer's disease; ONGENTYS tablets for the treatment of Parkinson's disease; PARSABIV, an intravenous injection for dialysis patients; STAYBLA tablets for overactive bladder; ONON capsules and dry syrups for bronchial asthma and allergic rhinitis; and JOYCLU intra-articular injection for the improvement of joint function, as well as RECALBON tablets for osteoporosis. In addition, it is developing products for esophageal, urothelial carcinoma, Hodgkin's lymphoma, ovarian, bladder, prostate, hepatocellular carcinoma, pancreatic, biliary tract, virus positive/negative solid carcinoma, gastric, esophageal, urothelial, hepatocellular, thyroid, colorectal, melanoma, acute myeloid leukemia, non-small cell lung cancer, primary central nervous system lymphoma, myelodysplastic syndrome, polymyositis/dermatomyositis, tachyarrhythmia, pemphigus, generalized scleroderma, enthesopathy, diabetic polyneuropathy, neurodegenerative, autoimmune, narcolepsy, and thrombosis. The company was founded in 1717 and is headquartered in Osaka, Japan.

Receive OPHLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ono Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

OPHLF Stock News Headlines

Ono Pharmaceutical Co. Ltd (OPHLF)
Here's what Wall Street expects from Ono Pharmaceutical's earnings
Here's what to expect from Ono Pharmaceutical's earnings
News for Ono Pharmaceutical
Fate Therapeutics Jumped On Supportive Trial Data
Gilead's Cancer Follies
Ono Pharmaceutical Co., Ltd. (OPHLF)
Ono Pharmaceutical Co Ltd (Japan) (OPHLF)
See More Headlines
Receive OPHLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ono Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

OPHLF Company Calendar

Today
12/08/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:OPHLF
Employees
3,687
Year Founded
N/A

Profitability

Net Income
$716.61 million
Pretax Margin
29.06%

Debt

Sales & Book Value

Annual Sales
$3.22 billion
Cash Flow
$1.70 per share
Book Value
$11.45 per share

Miscellaneous

Free Float
N/A
Market Cap
$12.41 billion
Optionable
Not Optionable
Beta
0.43

Key Executives

  • Mr. Gyo Sagara (Age 64)
    CEO, Pres & Representative Director
  • Mr. Shozo Matsuoka Ph.D.
    Corp. Exec. Officer and Exec. Director of Corp. Regulatory Compliance, Safety & QA
  • Yukio Tani
    Corp. Exec. Officer & Head of Corp. Communications
  • Katsuji Teranishi
    Corp. Officer and Chief Officer of Sales, Mkt, Wholesales Mgt., Planning & Primary Care Bus. Div.
  • Mr. Isao Ono (Age 63)
    Exec. Officer, Director of Corp. Research & Director
  • Mr. Hiroshi Ichikawa
    Corp. Officer & Sr. Director of Medical External Affairs
  • Mr. Toichi Takino Ph.D. (Age 54)
    Sr. Exec. Officer, Exec. Director of Discovery & Research and Director
  • Mr. Toshihiro Tsujinaka (Age 58)
    Sr. Exec. Officer, Exec. Director of Corp. Strategy & Planning and Director
  • Hiromu Habashita Ph.D.
    Corp. Officer and Deputy Exec. Director of Discovery & Research Division
  • Kiyoaki Idemitsu (Age 58)
    Exec. Officer, Exec. Director of Clinical Devel. & Director













OPHLF Stock - Frequently Asked Questions

How have OPHLF shares performed in 2022?

Ono Pharmaceutical's stock was trading at $25.0350 at the beginning of the year. Since then, OPHLF shares have decreased by 3.6% and is now trading at $24.1350.
View the best growth stocks for 2022 here
.

Are investors shorting Ono Pharmaceutical?

Ono Pharmaceutical saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 902,300 shares, a decrease of 39.2% from the October 31st total of 1,484,900 shares. Based on an average trading volume of 300 shares, the days-to-cover ratio is currently 3,007.7 days.
View Ono Pharmaceutical's Short Interest
.

What is Ono Pharmaceutical's stock symbol?

Ono Pharmaceutical trades on the OTCMKTS under the ticker symbol "OPHLF."

How do I buy shares of Ono Pharmaceutical?

Shares of OPHLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ono Pharmaceutical's stock price today?

One share of OPHLF stock can currently be purchased for approximately $24.14.

How much money does Ono Pharmaceutical make?

Ono Pharmaceutical (OTCMKTS:OPHLF) has a market capitalization of $12.41 billion and generates $3.22 billion in revenue each year. The company earns $716.61 million in net income (profit) each year or $1.46 on an earnings per share basis.

How many employees does Ono Pharmaceutical have?

The company employs 3,687 workers across the globe.

How can I contact Ono Pharmaceutical?

Ono Pharmaceutical's mailing address is 8-2 Kyutaromachi 1-chome Chuo-ku, Osaka M0, 541-8564. The official website for the company is www.ono.co.jp. The company can be reached via phone at (166) 263-5670 or via fax at 816-6263-2950.

This page (OTCMKTS:OPHLF) was last updated on 12/8/2022 by MarketBeat.com Staff